Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study
Clinical trial NCT04821583 · UNKNOWN
Trial details
- NCT number
- NCT04821583
- Sponsor
- Erasmus Medical Center
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2022-09-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.